LON:MTFB Motif Bio (MTFB) Share Price, News & Analysis → Urgent Nvidia Warning (From Altimetry) (Ad) Free MTFB Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range 0.50▼ 0.5052-Week Range N/AVolumeN/AAverage Volume33.38 million shsMarket Capitalization£3.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Motif Bio alerts: Email Address Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… About Motif Bio Stock (LON:MTFB)Motif Bio plc does not have any significant operations. It intends to identify a reverse takeover or other strategic transaction. Previously, the company was engaged in developing and commercializing pharmaceutical formulations. Motif Bio plc was incorporated in 2014 and is based in New York, New York.Read More Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… MTFB Stock News HeadlinesMarch 3, 2024 | lse.co.ukMTFB.L Share ChatMay 27, 2023 | lse.co.ukMTFB.L Regulatory NewsMay 3, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...April 22, 2023 | theguardian.comThe Christian history of the Green Man motifNovember 27, 2022 | finance.yahoo.comOchre Bio Announces Participation in Upcoming ConferencesSeptember 1, 2022 | investing.comMTFB_old Historical DataJanuary 23, 2022 | fool.comMotif Bio plc ADRs(MTFB)October 26, 2021 | finance.yahoo.comMTFB: Additional Data for Iclaprim Presented at ESCMID/ASM…May 3, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...October 26, 2021 | finance.yahoo.comMTFB: REVIVE-1 Results Published in Clinical Infectious DiseasesSee More Headlines Receive MTFB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Motif Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:MTFB CUSIPN/A CIKN/A Webwww.motifbio.com Phone609-608-0032FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio4.39 Quick Ratio3.36 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash Flow0.03 Book ValueGBX 15.50 per share Price / BookN/AMiscellaneous Outstanding Shares654,991,000Free FloatN/AMarket Cap£3.28 million OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Jonathan E. Gold (Age 48)Pres, Chief Bus. Officer & Exec. Director Comp: $618.39kLaurie DoyleHead of Investor Relations & Corp. CommunicationsMr. Robert Dickey IV (Age 65)M.B.A., Advisor Liam O'DonoghueCompany Sec.Ms. Lynda BerneConsultant - Commercial & Bus. StrategyDr. James S. MacDonald (Age 89)Toxicology Consultant Dr. Robert J. McCormack Ph.D.Regulatory ConsultantDr. Catherine D. Strader (Age 66)Drug Devel. Consultant Mr. Mark VanArendonkConsultant of Chemistry, Manufacturing & ControlsMore ExecutivesKey CompetitorsAptamer GroupLON:APTAFusion AntibodiesLON:FABIXICOLON:IXIOxford Cannabinoid TechnologiesLON:OCTPValiRxLON:VALView All Competitors MTFB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Motif Bio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Motif Bio investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Sirius Minerals (SXX), Egdon Resources (EDR), BlackRock (BLK), Endologix (ELGX), Global Blood Therapeutics (GBT), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG) and Aegean Marine Petroleum Network (ANW). How do I buy shares of Motif Bio? Shares of MTFB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:MTFB) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motif Bio plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
